Bill > SCR18

This concurrent resolution requests the State Auditor to study and report on the social and financial impacts of a proposed law, Senate Bill No. 967, which would require health insurance policies to cover intravenous ketamine therapy for depression. This requirement is being considered because ketamine has shown rapid antidepressant effects, particularly for treatment-resistant depression, and Hawaii law mandates such an assessment before requiring insurance coverage for new health services. The Auditor must submit their findings and any legislative recommendations to the Legislature by a specific date before the 2027 legislative session begins, and copies of this resolution will be sent to the Auditor and the Insurance Commissioner.

Health and Social Services

https://www.capitol.hawaii.gov/session/measure_indiv.aspx?billtype=SCR&billnumber=18&year=2026